TechNavio's analysts forecast the Global Plasma market to grow at a CAGR of 10.31 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the aging population. The Global Plasma market has also been witnessing the trend of increasing market consolidation. However, stringent regulations could pose a challenge to the growth of this market.... Research Beam Model: Research Beam Product ID: 16452 2000 USD New
Global Plasma Market 2012-2016
 

Global Plasma Market 2012-2016

Global Plasma Market 2012-2016

Category : Healthcare

request-discount
TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Global Plasma market to grow at a CAGR of 10.31 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the aging population. The Global Plasma market has also been witnessing the trend of increasing market consolidation. However, stringent regulations could pose a challenge to the growth of this market. 
TechNavio's report, the Global Plasma Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global plasma market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space CSL Behring LLC, Baxter International Inc., Grifols S.A., and Octapharma AG 
Other vendors mentioned in the report are Kedrion S.p.A., Biotest AG, Sanguine Corp., Cangene bioPharma Inc., Haemacure Corp., Kamada Inc., Omrix Biopharmaceuticals Inc., Vivostat A/S, Pfizer Inc., AstraZeneca plc, Takeda Pharmaceutical Inc., Novo Nordisk A/S, sanofi S.A., China Biologic Products Inc., Beijing Tiantan Biological Products Co. Ltd., Bharat Serums and Vaccines Ltd., and LFB Group.
Key questions answered in this report:
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

 

01. Executive Summary

02. Introduction

03. Market Coverage


Market Overview

       03.1Product Offerings

04. Market Landscape

04.1Market Size and Forecast

04.2Global Plasma Market by Plasma Derivative Segmentation

       04.3Five Force Analysis

05. Geographical Segmentation

06. Vendor Landscape


06.1Global Plasma Market

06.2Global Immunoglobulin Market

06.3Global Albumin Market

       Product Portfolio Matrix

07. Buying Criteria

08. Market Growth Drivers

09. Drivers and their Impact

10. Market Challenges

11. Impact of Drivers and Challenges

12. Market Trends

13. Key Vendor Analysis


       13.1 Baxter International Inc.

                Business Overview

                Key Information

SWOT Analysis

       13.2 CSL Behring LLC

               Business Overview 

               Key Information

 SWOT Analysis

      13.3 Grifols S.A.

Business Overview

Key Information

SWOT Analysis

     13.4 Octapharma AG

              Business Overview

              Key Information

              SWOT Analysis

14. Other Reports in this Series 



List of Exhibits:



Exhibit 1:     Composition of Blood Plasma

Exhibit 2:  Global Plasma Market 2012-2016 (US$ billion)

Exhibit 3: Global Plasma Market by Plasma Derivative Segmentation

Exhibit 4: Global Plasma Market by Plasma Derivative Segmentation 2012

       Exhibit 5: Global Plasma Market by Geographical Segmentation 2012

       Exhibit 6: Global Plasma Market by Vendor Segmentation 2012

Exhibit 7:     Global Immunoglobulin Market by Vendor Segmentation 2012

Exhibit 8:     Global Albumin Market by Vendor Segmentation 2012

Exhibit 9:     Business Segmentation of Baxter International Inc.

Exhibit 10:   Business Segmentation of Grifols S.A.

Exhibit 11:   Business Segmentation of Octapharma AG



Enquiry Before Buy